neutral
Recently
Major drugmakers agree to price cuts under new White House affordability push
Several major pharmaceutical companies agreed to cut U.
A group of leading U.S. and European pharmaceutical companies has reached agreements with President Donald Trump’s administration to voluntarily lower drug prices in the United States. The deals, signed by firms including Pfizer, Merck, Bristol Myers Squibb, Amgen, Gilead, Sanofi, and Novartis, link reduced prices to a three year exemption from proposed pharmaceutical specific tariffs, provided companies expand U.S. manufacturing.